Industry News
Researchers Studying Stem Cell Quiescence And Proliferation Hope Their Work Will Lead To New Therapies For Diseases Of The Blood
Jul 23, 2012
Not all adult stem cells are created equal. Some are busy regenerating worn out or damaged tissues, while their quieter brethren serve as a strategic back-up crew that only steps in when demand shoots up... Read More
Researchers Studying Stem Cell Quiescence And Proliferation Hope Their Work Will Lead To New Therapies For Diseases Of The Blood
Jul 23, 2012
Not all adult stem cells are created equal. Some are busy regenerating worn out or damaged tissues, while their quieter brethren serve as a strategic back-up crew that only steps in when demand shoots up... Read More
Hundreds Of Random Mutations In Leukemia Linked To Aging, Not Cancer
Jul 22, 2012
Hundreds of mutations exist in leukemia cells at the time of diagnosis, but nearly all occur randomly as a part of normal aging and are not related to cancer, new research shows. Scientists at Washington University School of Medicine in St. Louis have found that even in healthy people, stem cells in the blood routinely accumulate new mutations over the course of a person's lifetime... Read More
Blocking IL-6 Improved Response To Breast Cancer Drug Herceptin
Jul 22, 2012
Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant... Read More
Blocking IL-6 Improved Response To Breast Cancer Drug Herceptin
Jul 22, 2012
Breast cancer treatments such as Herceptin that target a marker called HER2 have dramatically improved outcomes for women with this type of cancer. But nearly half of these cancers are resistant to Herceptin from the start and almost all of them will eventually become resistant... Read More
PSA Prostate Cancer Screening For Men With Long Life Expectancies
Jul 21, 2012
Doctors should discuss with their patients fully the risks and benefits of PSA prostate cancer screening if the patient has a life expectance of more than ten years, an ASCO (American Society of Clinical Oncology) Panel advised today in a new evidence-based PCO (provisional clinical opinion)... Read More
PSA Prostate Cancer Screening For Men With Long Life Expectancies
Jul 21, 2012
Doctors should discuss with their patients fully the risks and benefits of PSA prostate cancer screening if the patient has a life expectance of more than ten years, an ASCO (American Society of Clinical Oncology) Panel advised today in a new evidence-based PCO (provisional clinical opinion)... Read More
Consuming Vitamin E Lowers Chance Of Liver Cancer
Jul 21, 2012
Individuals could reduce their risk of developing liver cancer by consuming more vitamin E, either from diet or vitamin supplements, according to a new study.` According to the study, published in the Journal of the National Cancer Institute, liver cancer is one of the leading causes of cancer mortality in world... Read More
Bladder Cancer Drug Instiladrin™ Enters Phase II Trial After Being Cleared By FDA And RAC
Jul 21, 2012
FKD Therapies Oy ('FKD' or the 'Company') has announced that it has received clearance from the United States (US) Food and Drug Administration (FDA) and the US Recombinant Advisory Committee (RAC) allowing it to commence a Phase II trial for Instiladrin™ in the US... Read More
Cell Glue Gives Insights Into Cancer
Jul 21, 2012
University of Queensland researchers have discovered an important step in how proteins glue cells together to form healthy tissues, a process that is often disturbed in diseases such as cancer and inflammation... Read More
Previous Page Next Page